Everest Medicines announced the appointment of Dr. Jennifer Yang as chief scientific officer. Dr. Yang has two decades of leadership experience in drug discovery and development at global pharmaceutical companies. Most recently, Dr. Yang served as vice president and head of China for Johnson & Johnson's Lung Cancer Initiative where she established and led a cross-sector research and development (R&D) organization for the creation of innovative solutions for lung cancer prevention, interception and cure. Jennifer transitioned into this role from Janssen (China) Research & Development Center, where she was the head of Discovery Center. Prior to joining Johnson and Johnson, Dr. Yang held global leadership positions at Eli Lilly and Company and Pfizer Inc. Oncology Research Unit in the United States.